Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Not surprisingly, our agenda is exceedingly modest. We hope to putter around the campus grounds, get some fresh air by promenading with the energetic official mascot, and peer into the telly. And what about you? This is a good time to stretch your own legs. You could also touch base with older folks who feel isolated or simply catch up on your reading. Well, whatever you do, keep your chin up and your mask on. Enjoy, and see you soon. …

French President Emmanuel Macron will meet with Sanofi (SNY) executives on May 19, after Sanofi chief executive Hudson caused outrage by saying the U.S. would have priority access to any Covid-19 vaccine the company develops, Bloomberg News writes. Hudson later walked back his comments by saying it was vital any vaccine reach all parts of the world.  The U.S., which expanded a vaccine partnership with the company in February, expects “that if we’ve helped you manufacture the doses at risk, we expect to get the doses first,” Hudson said.


The U.S. is sprinting headlong toward development and distribution of Covid-19 vaccines. But under an “America First” president, public health experts worry the U.S. could seek to gobble up early supplies and set the stage for prolonged devastation in the rest of the world, STAT says. Under “Operation Warp Speed,” the Trump administration hopes to have 300 million vaccine doses ready for domestic use by January 2021. It would mean prioritizing low-risk individuals in the U.S. over high-risk health care workers and other vulnerable people elsewhere.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!